Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page, indicating a minor document update.
    Difference
    0.1%
    Check dated 2026-03-07T04:47:42.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; no substantive study content, endpoints, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:33:59.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label changed from v3.4.0 to v3.4.1 with no impact on content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:15:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added standalone 'Results First Posted' and 'Last Update Posted' timestamps and removed the '(Estimated)' qualifiers for those fields. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-22T10:22:16.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:06:43.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added results-related sections (Best Overall Response Rate; Results First Submitted/Posted; Results Reporting Dates; Last Update Posted (Estimated)) and expanded site locations to include New Jersey and New York. Also added the Study Protocol and Statistical Analysis Plan PDF (Revision v3.3.3, 2024-05-03) and removed older entries such as the standalone New Jersey/Ny Locations and earlier Best Overall Response Rate entries.
    Difference
    2%
    Check dated 2025-12-23T22:05:51.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.